902 related articles for article (PubMed ID: 18455473)
81. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
82. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P
Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
[TBL] [Abstract][Full Text] [Related]
83. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
Kumar S; Wairagkar NS; Mahanta J
Indian J Cancer; 2001; 38(2-4):72-5. PubMed ID: 12593442
[TBL] [Abstract][Full Text] [Related]
84. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
85. [Real-time quantitative PCR assay of Epstein-Barr virus in whole blood cells of nasopharyngeal carcinoma patients].
Wang H; Deng L; Chen SH; Wang SQ; Cao Y
Shi Yan Sheng Wu Xue Bao; 2003 Feb; 36(1):32-6. PubMed ID: 12751207
[TBL] [Abstract][Full Text] [Related]
86. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I
J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
[TBL] [Abstract][Full Text] [Related]
87. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
[TBL] [Abstract][Full Text] [Related]
88. [The purification and application of Epstein-Barr virus gp125].
Wang G; Pi G; Gu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
[TBL] [Abstract][Full Text] [Related]
89. Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.
Dardari R; Hinderer W; Lang D; Benider A; El Gueddari B; Joab I; Benslimane A; Khyatti M
J Clin Microbiol; 2001 Sep; 39(9):3164-70. PubMed ID: 11526145
[TBL] [Abstract][Full Text] [Related]
90. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
[TBL] [Abstract][Full Text] [Related]
91. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
Chan KC; Hung EC; Woo JK; Chan PK; Leung SF; Lai FP; Cheng AS; Yeung SW; Chan YW; Tsui TK; Kwok JS; King AD; Chan AT; van Hasselt AC; Lo YM
Cancer; 2013 May; 119(10):1838-44. PubMed ID: 23436393
[TBL] [Abstract][Full Text] [Related]
92. [Immunoglobulin A serum antibodies against the capsid antigen of Epstein-Barr virus in the differential diagnosis and follow-up of nasopharyngeal cancer].
Pavelka R; Popow-Kraupp T; Radaszkiewicz T
Wien Klin Wochenschr; 1985 Jul; 97(14):588-95. PubMed ID: 2996246
[TBL] [Abstract][Full Text] [Related]
93. Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.
Paramita DK; Fatmawati C; Juwana H; van Schaijk FG; Fachiroh J; Haryana SM; Middeldorp JM
J Med Virol; 2011 Apr; 83(4):665-78. PubMed ID: 21328382
[TBL] [Abstract][Full Text] [Related]
94. Circulating immune complexes in patients with nasopharyngeal carcinoma.
Wolf GT; Wolfe RA
Laryngoscope; 1990 Mar; 100(3):302-8. PubMed ID: 1689798
[TBL] [Abstract][Full Text] [Related]
95. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
[TBL] [Abstract][Full Text] [Related]
96. IgA directed against early antigen of Epstein-Barr virus is no specific marker for the diagnosis of nasopharyngeal carcinoma.
Sigel G; Schillinger M; Henninger K; Bauer G
J Med Virol; 1994 Jul; 43(3):222-7. PubMed ID: 7931181
[TBL] [Abstract][Full Text] [Related]
97. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
98. [Detection of serum Epstein-Barr virus antibody level by ELISA in normal populations and nasopharyngeal carcinoma patients in Zhongshan City of China].
Cheng MT; Cheng WM; Ji MF; Liang JS
Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):817-8, 822. PubMed ID: 12297441
[TBL] [Abstract][Full Text] [Related]
99. Combining Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma: A meta-analysis.
Lian M
Auris Nasus Larynx; 2023 Jun; 50(3):430-439. PubMed ID: 36241564
[TBL] [Abstract][Full Text] [Related]
100. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
